Progression of traction bronchiectasis/bronchiolectasis in interstitial lung abnormalities is associated with increased all-cause mortality: Age Gene/Environment Susceptibility-Reykjavik Study

Autor: Gunnar Gudmundsson, David C. Christiani, Hiroshi Honda, Mizuki Nishino, David A. Lynch, Akinori Hata, Tetsuro Araki, Takuya Hino, Osamu Honda, Vilmundur Gudnason, Noriyuki Tomiyama, Rachel K. Putman, Gary M. Hunninghake, Hiroto Hatabu, Raul San Jose Estepar, Kousei Ishigami, Masahiro Jinzaki, George R. Washko, Masahiro Yanagawa, Takeshi Kamitani, Takeshi Johkoh, Elias F. Gudmundsson, Yoshitake Yamada, Tomoyuki Hida, Vladimir I. Valtchinov, Junwei Lu
Rok vydání: 2021
Předmět:
medicine.medical_specialty
BMI
body mass index

R895-920
Gastroenterology
Article
Pulmonary fibrosis
030218 nuclear medicine & medical imaging
OS
overall survival

TB
traction bronchiectasis

TBI-R2
traction bronchiectasis/bronchiolecetasis index on Round 2

Medical physics. Medical radiology. Nuclear medicine
03 medical and health sciences
0302 clinical medicine
Usual interstitial pneumonia
Internal medicine
medicine
AGES-Reykjavik Study
Age Gene/Environment Susceptibility-Reykjavik Study

Radiology
Nuclear Medicine and imaging

Honeycombing
Interstitial lung abnormality
Traction bronchiectasis
Age Gene/Environment Susceptibility-Reykjavik Study
Lung
Bronchiectasis
Proportional hazards model
business.industry
Hazard ratio
Interstitial lung disease
medicine.disease
HR
hazard ratio

medicine.anatomical_structure
030220 oncology & carcinogenesis
TBI
traction bronchiectasis/bronchiolecetasis index

ILD
interstitial lung disease

ILA
interstitial lung abnormalities

business
Zdroj: European Journal of Radiology Open, Vol 8, Iss, Pp 100334-(2021)
European Journal of Radiology Open
ISSN: 2352-0477
Popis: Highlights • TB progressed in 58.4 % (191/327). More than 90 % of participants with TBI = 2 or 3 (51/56) had TB progression. • TB progression was associated with increased mortality (adjusted HR = 1.68, P
Purpose The aim of this study is to assess the role of traction bronchiectasis/bronchiolectasis and its progression as a predictor for early fibrosis in interstitial lung abnormalities (ILA). Methods Three hundred twenty-seven ILA participants out of 5764 in the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study who had undergone chest CT twice with an interval of approximately five-years were enrolled in this study. Traction bronchiectasis/bronchiolectasis index (TBI) was classified on a four-point scale: 0, ILA without traction bronchiectasis/bronchiolectasis; 1, ILA with bronchiolectasis but without bronchiectasis or architectural distortion; 2, ILA with mild to moderate traction bronchiectasis; 3, ILA and severe traction bronchiectasis and/or honeycombing. Traction bronchiectasis (TB) progression was classified on a five-point scale: 1, Improved; 2, Probably improved; 3, No change; 4, Probably progressed; 5, Progressed. Overall survival (OS) among participants with different TB Progression Score and between the TB progression group and No TB progression group was also investigated. Hazard radio (HR) was estimated with Cox proportional hazards model. Results The higher the TBI at baseline, the higher TB Progression Score (P
Databáze: OpenAIRE